Home> Products> sglt2 and dpp 4 inhibitor combination

{ "products": [ { "_id": "662b998cf7fe09029cbf4fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sacubitril 49mg and valsartan 51mg tablets", "description": "SACUBRIGHT 100 \nSacubitril 49mg, Valsartan 51mg\nSACUBRIGHT 100 is a combination medication containing Sacubitril 49 mg and Valsartan 51 mg, formulated to support patients diagnosed with certain types of chronic heart failure. This dual-ingredient therapy belongs to a class of medicines known as angiotensin receptor neprilysin inhibitors (ARNIs). It is specifically designed to improve heart function, reduce strain on the cardiovascular system, and lower the risk of hospitalization related to heart failure.\n\nHeart failure is a long-term condition in which the heart is unable to pump blood efficiently enough to meet the body’s needs. SACUBRIGHT 100 works through two complementary mechanisms to enhance cardiovascular performance and promote better long-term outcomes when used under medical supervision.\n\nThis strength (100 mg total combination dose) is typically prescribed as part of a titration schedule, where dosage may be gradually increased based on patient tolerance and clinical response.\n\nHow SACUBRIGHT 100 Works\n\nSACUBRIGHT 100 combines two active ingredients that target different pathways involved in heart failure:\n\n1. Sacubitril (Neprilysin Inhibitor)\n\nSacubitril blocks the enzyme neprilysin, which is responsible for breaking down beneficial peptides in the body. By inhibiting this enzyme, sacubitril increases levels of natural substances that:\n\nRelax blood vessels\n\nReduce sodium retention\n\nDecrease fluid buildup\n\nLower blood pressure\n\nThis helps reduce the workload on the heart.\n\n2. Valsartan (Angiotensin II Receptor Blocker – ARB)\n\nValsartan blocks the action of angiotensin II, a hormone that causes blood vessels to constrict and increases blood pressure. By blocking this hormone, valsartan:\n\nDilates blood vessels\n\nReduces blood pressure\n\nDecreases strain on the heart\n\nPrevents harmful heart remodeling\n\nTogether, these two components provide a comprehensive approach to managing heart failure by improving circulation and reducing stress on the heart muscle.\n\nUses of SACUBRIGHT 100\n\nSACUBRIGHT 100 is primarily prescribed for:\n\n1. Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)\n\nIt is indicated for patients whose heart pumping capacity is reduced. The medication helps:\n\nImprove heart efficiency\n\nReduce symptoms such as shortness of breath and fatigue\n\nLower the risk of hospitalization\n\nImprove overall survival in eligible patients\n\n2. Cardiovascular Risk Reduction\n\nIn certain patients, SACUBRIGHT 100 may reduce the risk of cardiovascular-related death when used as part of a comprehensive heart failure management plan.\n\nKey Benefits of SACUBRIGHT 100\n1. Improved Heart Function\n\nBy supporting both vasodilation and fluid balance, SACUBRIGHT 100 helps the heart pump more effectively.\n\n2. Reduced Hospitalizations\n\nClinical use of sacubitril and valsartan combination therapy has been associated with a lower rate of hospital admissions due to worsening heart failure.\n\n3. Lower Cardiovascular Mortality Risk\n\nAppropriate use may reduce the risk of heart-related death in patients with chronic heart failure.\n\n4. Dual Mechanism Advantage\n\nUnlike traditional single-mechanism therapies, SACUBRIGHT 100 works through two pathways, offering broader cardiovascular support.\n\n5. Enhanced Quality of Life\n\nPatients may experience improvements in:\n\nExercise tolerance\n\nEnergy levels\n\nBreathing comfort\n\nOverall daily functioning\n\n6. Structured Dose Flexibility\n\nThe 100 mg combination strength allows healthcare providers to adjust therapy progressively based on patient response and tolerability.\n\nDosage and Administration\n\nSACUBRIGHT 100 should be taken exactly as prescribed by a healthcare professional.\n\nIt is usually taken twice daily.\n\nTablets may be taken with or without food.\n\nDo not stop or change dosage without consulting your doctor.\n\nBefore starting SACUBRIGHT 100, patients may need to discontinue ACE inhibitors for a specified period to reduce the risk of complications.\n\nRegular monitoring of blood pressure, kidney function, and potassium levels is typically recommended during treatment.\n\nPossible Side Effects of SACUBRIGHT 100\n\nLike all medications, SACUBRIGHT 100 may cause side effects. Many are manageable and improve over time.\n\nCommon Side Effects\n\nLow blood pressure (hypotension)\n\nDizziness\n\nFatigue\n\nIncreased potassium levels (hyperkalemia)\n\nMild kidney function changes\n\nPatients may feel lightheaded, especially when standing up quickly.\n\nKidney-Related Effects\n\nMonitoring is important as the medication may affect kidney function in some individuals, particularly those with pre-existing kidney disease.\n\nElectrolyte Imbalance\n\nElevated potassium levels may occur, which can cause:\n\nMuscle weakness\n\nIrregular heartbeat\n\nNumbness or tingling\n\nRoutine blood tests help detect and manage this risk.\n\nRare but Serious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSwelling of face, lips, or throat (angioedema)\n\nSevere allergic reactions\n\nPersistent fainting\n\nSevere decrease in urine output\n\nAngioedema is rare but potentially serious and requires urgent care.\n\nPrecautions and Warnings\n\nNot recommended during pregnancy due to risk of fetal harm.\n\nBreastfeeding mothers should consult a healthcare provider before use.\n\nPatients with severe liver impairment should use caution.\n\nAvoid potassium supplements or salt substitutes unless advised by a doctor.\n\nInform your physician about all medications being taken to avoid interactions.\n\nSACUBRIGHT 100 should not be used together with ACE inhibitors or certain other medications without proper medical guidance.\n\nWho Should Avoid SACUBRIGHT 100?\n\nThis medication may not be suitable for individuals who:\n\nHave a history of angioedema related to ACE inhibitors or ARBs\n\nAre pregnant\n\nHave severe liver dysfunction\n\nAre unable to tolerate ARB therapy\n\nA full medical evaluation is essential before starting treatment.\n\nStorage Instructions\n\nStore at room temperature.\n\nKeep away from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use after the expiration date printed on the packaging.\n\nConclusion\nSACUBRIGHT 100 (Sacubitril 49 mg + Valsartan 51 mg) represents an advanced therapeutic approach in the management of chronic heart failure with reduced ejection fraction. By combining neprilysin inhibition with angiotensin receptor blockade, it delivers comprehensive cardiovascular protection and helps reduce the strain placed on the heart.\n", "price": 690.0, "discountamount": 207.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARB", "life", "51mg", "49mg", "enzyme", "quality", "symptoms", "Valsartan", "neprilysin", "Sacubitril", "SACUBRIGHT", "individuals", "heart health", "heart failure", "blood vessels", "dual benefits", "blood pressure", "increased levels", "unique combination", "beneficial peptides", "pharmaceutical blend", "comprehensive support", "angiotensin receptor blocker" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 766, "imageuri": "https://productimages.withfloats.com/actual/662b998e670596731f8d9f41.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b998e670596731f8d9f41.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:09:48.199Z", "updatedon": "2026-02-18T07:49:26.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacubitril-49mg-and-valsartan-51mg-tablets/766", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUBRIGHT 100", "category": "CARDIOLOGYRANGE", "tags": [ "sacubitril 49mg and valsartan 51mg tablet uses", "sacubitril 49mg valsartan 51mg dosage guide", "sacubitril valsartan 49/51 for heart failure", "how does sacubitril 49mg valsartan 51mg work", "sacubitril valsartan 49/51 side effects", "when to take sacubitril valsartan 49/51", "sacubitril 49mg valsartan 51mg twice daily dose", "sacubitril valsartan 49/51 monitoring parameters", "is sacubitril 49/51 a high dose", "can sacubitril valsartan 49/51 cause low blood pressure", "buy sacubitril valsartan 49/51 tablets online", "sacubitril valsartan 49/51 pharmacy price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a1d7da71f450faabc228b8d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "description": "Managing Type 2 diabetes requires a comprehensive approach that helps control blood sugar levels while reducing the risk of long-term complications. The Gliclazide and Dapagliflozin combination is a modern and effective treatment option prescribed by healthcare professionals to improve glycemic control in adults with Type 2 diabetes mellitus. This combination works through two different mechanisms to help maintain healthy blood glucose levels, making it a preferred choice for patients who need better diabetes management.\n\nIf you are looking for a reliable diabetes treatment option, understanding the benefits, uses, and working mechanism of the Gliclazide and Dapagliflozin combination can help you make an informed decision in consultation with your healthcare provider.\n\nWhat is Gliclazide and Dapagliflozin Combination?\n\nThe Gliclazide and Dapagliflozin combination is an oral anti-diabetic medication used to control blood sugar levels in patients with Type 2 diabetes. It combines two powerful medicines:\n\nGliclazide – A sulfonylurea that stimulates the pancreas to release more insulin.\nDapagliflozin – An SGLT2 inhibitor that helps the kidneys remove excess glucose through urine.\n\nTogether, these medicines provide dual-action blood sugar control and help patients achieve better glycemic targets when diet, exercise, and single-drug therapy are insufficient.\n\nHow Does Gliclazide and Dapagliflozin Combination Work?\n\nThe effectiveness of this combination lies in its complementary mechanisms of action.\n\nGliclazide Action\n\nGliclazide works by stimulating the beta cells in the pancreas to produce and release more insulin. Increased insulin production helps transport glucose from the bloodstream into body cells, where it is used for energy.\n\nDapagliflozin Action\n\nDapagliflozin blocks the Sodium-Glucose Co-Transporter 2 (SGLT2) protein in the kidneys. This action reduces glucose reabsorption and allows excess sugar to be eliminated through urine, lowering blood glucose levels.\n\nCombined Benefits\n\nWhen used together, Gliclazide and Dapagliflozin help:\n\nReduce fasting blood sugar levels\nLower post-meal glucose spikes\nImprove HbA1c levels\nSupport long-term diabetes management\nProvide complementary glucose-lowering effects\nUses of Gliclazide and Dapagliflozin Combination\n\nHealthcare professionals commonly prescribe this combination for:\n\nType 2 Diabetes Mellitus\n\nThe primary use of the Gliclazide and Dapagliflozin combination is the treatment of Type 2 diabetes in adults whose blood sugar levels are not adequately controlled by lifestyle modifications alone.\n\nImproved Glycemic Control\n\nThis medication helps patients achieve better glycemic control and maintain stable blood glucose levels throughout the day.\n\nCombination Diabetes Therapy\n\nIt is often recommended when monotherapy with a single anti-diabetic medication fails to provide satisfactory results.\n\nLong-Term Diabetes Management\n\nThe combination can be used as part of a comprehensive diabetes management plan that includes healthy eating, exercise, and regular monitoring.\n\nBenefits of Gliclazide and Dapagliflozin Combination\n1. Dual Mechanism of Action\n\nThe combination attacks high blood sugar from two different angles, resulting in more effective glucose control.\n\n2. Better HbA1c Reduction\n\nPatients often experience significant reductions in HbA1c levels compared to treatment with a single medication.\n\n3. Effective Fasting and Postprandial Control\n\nThe medicine helps manage both fasting blood glucose and post-meal sugar spikes.\n\n4. Convenient Treatment Option\n\nCombining two medications into one treatment regimen can improve patient compliance and simplify diabetes management.\n\n5. Supports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin may contribute to modest weight reduction due to the elimination of excess glucose through urine.\n\n6. Cardiovascular Benefits\n\nDapagliflozin has been associated with cardiovascular benefits in certain patients, making it an attractive option for individuals with Type 2 diabetes and cardiovascular risk factors.\n\n7. Reduced Risk of Diabetes Complications\n\nMaintaining better blood sugar control may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.\n\nWhy Choose Gliclazide and Dapagliflozin Combination?\n\nThe growing popularity of this combination therapy stems from its ability to provide comprehensive blood sugar management. Physicians often recommend it because:\n\nIt targets multiple pathways involved in glucose regulation.\nIt provides strong glycemic control.\nIt helps reduce HbA1c effectively.\nIt offers potential weight-related benefits.\nIt supports long-term diabetes care goals.\n\nPatients seeking improved diabetes control often find this combination beneficial when prescribed and monitored by a healthcare professional.\n\nRecommended Dosage\n\nThe dosage of the Gliclazide and Dapagliflozin combination should always be determined by a healthcare provider based on:\n\nAge\nBlood glucose levels\nHbA1c values\nMedical history\nKidney function\nResponse to treatment\n\nPatients should take the medication exactly as prescribed and should not alter the dosage without medical advice.\n\nPrecautions Before Using Gliclazide and Dapagliflozin Combination\n\nBefore starting treatment, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart conditions\nFrequent urinary tract infections\nHistory of diabetic ketoacidosis\nSevere dehydration\nLow blood pressure\n\nPregnant and breastfeeding women should consult their healthcare provider before using this medication.\n\nPossible Side Effects\n\nLike all medications, the Gliclazide and Dapagliflozin combination may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased urination\nThirst\nHeadache\nDizziness\nFatigue\nMild gastrointestinal discomfort\nHypoglycemia Symptoms\n\nSince Gliclazide stimulates insulin release, some patients may experience low blood sugar, especially when meals are skipped.\n\nSymptoms may include:\n\nSweating\nHunger\nTrembling\nWeakness\nConfusion\nRapid heartbeat\nUrinary and Genital Infections\n\nDapagliflozin increases glucose excretion through urine, which may increase the likelihood of:\n\nUrinary tract infections\nGenital fungal infections\n\nPrompt medical attention should be sought if symptoms occur.\n\nLifestyle Tips for Better Diabetes Control\n\nFor optimal results with the Gliclazide and Dapagliflozin combination, patients should follow a healthy lifestyle.\n\nMaintain a Balanced Diet\n\nFocus on:\n\nWhole grains\nVegetables\nFruits in moderation\nLean proteins\nHealthy fats\n\nAvoid excessive consumption of sugary foods and beverages.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and supports blood sugar control. Aim for at least 150 minutes of moderate exercise per week, as advised by your healthcare provider.\n\nMonitor Blood Sugar\n\nRegular blood glucose monitoring helps track treatment effectiveness and allows timely adjustments when necessary.\n\nStay Hydrated\n\nBecause Dapagliflozin increases urinary glucose excretion, adequate hydration is important to prevent dehydration.\n\nAttend Regular Checkups\n\nRoutine medical visits help monitor:\n\nHbA1c levels\nKidney function\nBlood pressure\nOverall diabetes control\nWho Can Benefit from Gliclazide and Dapagliflozin Combination?\n\nThis combination may be suitable for:\n\nAdults with Type 2 diabetes\nPatients requiring stronger glucose control\nIndividuals not achieving targets with single-drug therapy\nPatients seeking a dual-action diabetes treatment approach\nIndividuals requiring comprehensive glycemic management under medical supervision\nConclusion\n\nThe Gliclazide and Dapagliflozin combination is an advanced and effective treatment option for adults with Type 2 diabetes mellitus. By combining the insulin-stimulating action of Gliclazide with the glucose-eliminating benefits of Dapagliflozin, this therapy provides comprehensive blood sugar control and supports long-term diabetes management goals.\n\nWith benefits such as improved HbA1c reduction, fasting and post-meal glucose control, convenient therapy, and potential cardiovascular advantages, this combination has become an important choice in modern diabetes care. When used alongside a healthy diet, regular exercise, and proper medical supervision, the Gliclazide and Dapagliflozin combination can help patients achieve better glycemic control and improve their overall quality of life.", "price": 470.0, "discountamount": 141.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2433, "imageuri": "https://productimages.withfloats.com/actual/6a1d7da92f2aa2676dd01915.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1d7da92f2aa2676dd01915.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-01T12:40:07.196Z", "updatedon": "2026-06-04T07:19:16.331Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclazide-sr-60mg-and-dapagliflozin-10mg-tablet/2433", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclaglaze DAPA 60-10", "category": "DIABETIC RANGE", "tags": [ "gliclazide and dapagliflozin combination", "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "gliclazide and dapagliflozin", "gliclazide and dapagliflozin together", "gliclazide dapagliflozin", "Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets", "Buy Gliclazide SR 60 mg Dapagliflozin 10 mg Tablets Online", "Type 2 Diabetes Treatment Tablets", "Gliclazide and Dapagliflozin Diabetes Medicine", "Gliclazide SR 60 mg Dapagliflozin 10 mg Product Image", "Best Tablets for Type 2 Diabetes Management", "Blood Sugar Control Tablets Gliclazide Dapagliflozin", "Gliclazide SR and Dapagliflozin Combination Tablets", "Diabetes Management Medicine Gliclazide Dapagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69cf8589ee7201fd096ce0b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atorvastatin 80 mg and Ezetimibe 10 mg", "description": "Introduction\n\nATOVASTRIN EZ 80/10 is a powerful combination therapy formulated with Atorvastatin 80 mg and Ezetimibe 10 mg, designed to provide comprehensive management of high cholesterol levels. This dual-action medication is widely prescribed for patients who require aggressive lipid-lowering therapy, especially those at high risk of cardiovascular diseases such as heart attack and stroke.\n\nIn today’s fast-paced lifestyle, unhealthy eating habits, stress, and lack of physical activity have significantly increased the prevalence of high cholesterol. If left untreated, it can lead to serious complications including atherosclerosis (narrowing of arteries), heart disease, and other life-threatening conditions. ATOVASTRIN EZ 80/10 offers an advanced and effective solution to control cholesterol levels and improve overall heart health.\n\nWhat is ATOVASTRIN EZ 80/10?\n\nATOVASTRIN EZ 80/10 is a fixed-dose combination of:\n\nAtorvastatin 80 mg – A statin that reduces cholesterol production in the liver\nEzetimibe 10 mg – A cholesterol absorption inhibitor that reduces dietary cholesterol uptake from the intestine\n\nThis combination works synergistically to lower both endogenous (produced by the body) and exogenous (dietary) cholesterol, providing superior lipid control compared to monotherapy.\n\nHow ATOVASTRIN EZ 80/10 Works\n\nATOVASTRIN EZ 80/10 works through a dual mechanism:\n\n1. Reduction of Cholesterol Production\n\nAtorvastatin inhibits the HMG-CoA reductase enzyme in the liver, which is responsible for cholesterol synthesis. This leads to a significant reduction in LDL (bad cholesterol).\n\n2. Decreased Cholesterol Absorption\n\nEzetimibe blocks the absorption of cholesterol from the small intestine, reducing the amount of cholesterol entering the bloodstream.\n\n3. Improved Lipid Profile\n\nThe combination helps in:\n\nLowering LDL cholesterol\nReducing total cholesterol\nDecreasing triglycerides\nIncreasing HDL (good cholesterol)\n4. Prevention of Plaque Formation\n\nBy lowering cholesterol levels, it helps prevent plaque buildup in arteries, reducing the risk of cardiovascular diseases.\n\nUses of ATOVASTRIN EZ 80/10\n\nATOVASTRIN EZ 80/10 is used for:\n\nTreatment of high cholesterol (hyperlipidemia)\nManagement of mixed dyslipidemia\nPrevention of heart attack and stroke\nReduction of cardiovascular risk in high-risk patients\nTreatment of patients not adequately controlled on statin therapy alone\nKey Benefits of ATOVASTRIN EZ 80/10\n1. Powerful Dual Action\n\nCombines two effective mechanisms for superior cholesterol reduction.\n\n2. Significant LDL Reduction\n\nHelps in aggressively lowering bad cholesterol levels.\n\n3. Cardiovascular Protection\n\nReduces the risk of heart attack, stroke, and other heart-related complications.\n\n4. Improved Overall Lipid Profile\n\nBalances cholesterol levels by lowering LDL and increasing HDL.\n\n5. Convenient Combination Therapy\n\nEliminates the need for multiple medications, improving patient compliance.\n\n6. Suitable for High-Risk Patients\n\nIdeal for individuals with diabetes, hypertension, or existing heart conditions.\n\nHow to Use ATOVASTRIN EZ 80/10\nTake ATOVASTRIN EZ 80/10 as prescribed by your doctor\nUsually taken once daily, with or without food\nSwallow the tablet whole with water\nFollow a cholesterol-lowering diet and healthy lifestyle for best results\nRegular lipid profile monitoring is recommended\nSide Effects of ATOVASTRIN EZ 80/10\n\nLike all medications, ATOVASTRIN EZ 80/10 may cause side effects:\n\nCommon Side Effects:\nHeadache\nMuscle pain (myalgia)\nAbdominal discomfort\nNausea\nLess Common Side Effects:\nElevated liver enzymes\nFatigue\nDiarrhea\nSerious Side Effects (Rare):\nSevere muscle breakdown (rhabdomyolysis)\nLiver dysfunction\nAllergic reactions\nPrecautions and Warnings\nAvoid alcohol consumption as it may increase liver-related risks\nNot recommended during pregnancy and breastfeeding\nInform your doctor if you have liver or kidney disease\nRegular monitoring of liver function tests is required\nInform your doctor about all medications you are taking to avoid interactions\nWho Should Use ATOVASTRIN EZ 80/10?\n\nThis medication is ideal for:\n\nPatients with high cholesterol levels\nIndividuals at high risk of cardiovascular diseases\nPatients not responding to statin therapy alone\nPeople with diabetes or hypertension needing lipid control\nStorage Instructions\nStore in a cool and dry place\nKeep away from direct sunlight\nKeep out of reach of children\nWhy Choose ATOVASTRIN EZ 80/10?\n\nATOVASTRIN EZ 80/10 stands out because of:\n\nAdvanced dual-action formulation\nProven clinical effectiveness\nConvenient once-daily dosage\nComprehensive lipid management\nTrusted by healthcare professionals\nConclusion\n\nATOVASTRIN EZ 80/10 (Atorvastatin 80 mg + Ezetimibe 10 mg) is a highly effective and advanced therapy for managing high cholesterol and reducing cardiovascular risks. Its dual-action mechanism ensures maximum cholesterol reduction by targeting both production and absorption pathways.", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2366, "imageuri": "https://productimages.withfloats.com/actual/69cf8591d572ad80ed9cf5b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cf8591d572ad80ed9cf5b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-03T09:16:57.37Z", "updatedon": "2026-04-03T09:16:57.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//atorvastatin-80-mg-and-ezetimibe-10-mg/2366", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ 80/10", "category": "CARDIOLOGYRANGE", "tags": [ "atorvastatin 80 mg and ezetimibe 10 mg tablets uses", "atorvastatin 80 mg ezetimibe 10 mg combination benefits", "atorvastatin ezetimibe 80/10 dosage and uses", "atorvastatin 80 mg ezetimibe 10 mg mechanism of action", "buy atorvastatin 80 mg ezetimibe 10 mg tablets online", "atorvastatin 80/10 tablets wholesale price india", "atorvastatin ezetimibe tablets b2b supplier", "where to buy atorvastatin ezetimibe tablets in india", "atorvastatin ezetimibe tablets best price", "fast delivery atorvastatin ezetimibe bulk order" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69942f823b20a66d9dcf9458", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.", "price": 703.0, "discountamount": 211.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2308, "imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-17T09:06:10.4Z", "updatedon": "2026-04-08T08:59:59.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS INDUS", "category": "ASTHMARANGE", "tags": [ "indacaterol maleate", "fdc of indacaterol maleate uses", "fdc of indacaterol maleate uses in hindi", "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "indacaterol maleate and glycopyrronium bromide", "indacaterol maleate glycopyrronium bromide price", "fdc of indacaterol maleate" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698af4f53f78e8d74694007f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "rosuvastatin ezetimibe 40 10 mg", "description": "REVOSTATIN EZ 40 is a fixed-dose combination of Rosuvastatin 40 mg and Ezetimibe 10 mg, formulated to provide advanced and effective management of high cholesterol levels. This powerful dual-action therapy is prescribed for patients who require intensive lipid-lowering treatment, particularly those at high risk of cardiovascular diseases.\n\nHigh cholesterol, especially elevated LDL (bad cholesterol), is a major contributor to heart attacks, strokes, and atherosclerosis. REVOSTATIN EZ 40 works through two complementary mechanisms—reducing cholesterol production in the liver and limiting cholesterol absorption from the intestine—offering superior cholesterol control compared to single-agent therapy.\n\nProduct Description\n\nREVOSTATIN EZ 40 combines a high-potency statin with a cholesterol absorption inhibitor to deliver comprehensive lipid management. Rosuvastatin belongs to the statin class of medicines, while Ezetimibe selectively blocks cholesterol uptake in the digestive tract. Together, they significantly reduce LDL cholesterol, total cholesterol, and triglycerides, while helping maintain or modestly increase HDL (good cholesterol).\n\nThis combination is especially beneficial for patients who do not achieve target cholesterol levels with statin therapy alone or those with a high cardiovascular risk profile. REVOSTATIN EZ 40 is typically prescribed alongside lifestyle modifications such as a cholesterol-controlled diet, regular exercise, and weight management.\n\nUses of REVOSTATIN EZ 40\n\nREVOSTATIN EZ 40 is indicated for the treatment and management of:\n\n1. Primary Hypercholesterolemia\n\nUsed in patients with high LDL cholesterol levels that are not adequately controlled by diet and exercise alone.\n\n2. Mixed Dyslipidemia\n\nHelps manage elevated cholesterol and triglyceride levels simultaneously.\n\n3. Prevention of Cardiovascular Diseases\n\nReduces the risk of heart attack, stroke, and other cardiovascular events in high-risk individuals, including patients with diabetes, hypertension, or a history of heart disease.\n\n4. Familial Hypercholesterolemia\n\nPrescribed in certain cases of inherited cholesterol disorders where aggressive lipid lowering is required.\n\nHow REVOSTATIN EZ 40 Works\n\nThe effectiveness of REVOSTATIN EZ 40 lies in its dual mechanism of action:\n\nRosuvastatin\n\nInhibits HMG-CoA reductase, an enzyme responsible for cholesterol synthesis in the liver\n\nReduces LDL cholesterol and triglycerides\n\nImproves overall lipid profile\n\nStabilizes plaque in blood vessels, reducing cardiovascular risk\n\nEzetimibe\n\nBlocks the absorption of cholesterol from the small intestine\n\nReduces the amount of cholesterol delivered to the liver\n\nEnhances the cholesterol-lowering effect of statins\n\nBy targeting both cholesterol production and absorption, REVOSTATIN EZ 40 delivers deeper and more sustained cholesterol reduction.\n\nKey Benefits of REVOSTATIN EZ 40\n1. Superior LDL Cholesterol Reduction\n\nThe combination therapy offers significantly greater LDL lowering compared to statin monotherapy.\n\n2. Comprehensive Lipid Control\n\nEffectively reduces total cholesterol and triglycerides while supporting healthy HDL levels.\n\n3. Reduced Cardiovascular Risk\n\nHelps lower the risk of heart attacks, strokes, and other serious heart-related complications.\n\n4. Effective for High-Risk Patients\n\nIdeal for patients with diabetes, obesity, smoking history, or established cardiovascular disease.\n\n5. Convenient Combination Therapy\n\nCombines two powerful lipid-lowering agents in a single tablet, improving treatment adherence.\n\nSide Effects of REVOSTATIN EZ 40\n\nLike all medications, REVOSTATIN EZ 40 may cause side effects in some individuals. Most are mild to moderate and tend to improve with continued use.\n\nCommon Side Effects\n\nHeadache\n\nMuscle pain or weakness\n\nAbdominal discomfort\n\nNausea or indigestion\n\nFatigue\n\nMild increases in liver enzymes\n\nThese effects are usually temporary and manageable under medical supervision.\n\nLess Common but Serious Side Effects\n\nSeek immediate medical advice if you experience:\n\nSevere muscle pain or tenderness\n\nDark-colored urine\n\nUnusual fatigue or weakness\n\nYellowing of the skin or eyes (jaundice)\n\nAllergic reactions such as rash, itching, or swelling\n\nRegular monitoring of liver function and lipid levels is recommended during treatment.\n\nPrecautions and Safety Information\n\nREVOSTATIN EZ 40 should be taken exactly as prescribed by a healthcare professional.\n\nInform your doctor if you have liver disease, kidney problems, or a history of muscle disorders.\n\nAvoid excessive alcohol consumption during treatment.\n\nPregnant and breastfeeding women should not use this medication.\n\nContinue a cholesterol-lowering diet and healthy lifestyle for optimal results.\nConclusion\nREVOSTATIN EZ 40 (Rosuvastatin 40 mg and Ezetimibe 10 mg) is a highly effective and well-tolerated combination therapy designed for advanced cholesterol management. By addressing cholesterol from two critical pathways—production and absorption—it offers superior lipid control and enhanced cardiovascular protection.", "price": 265.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2299, "imageuri": "https://productimages.withfloats.com/actual/698af4fc8c165a34c7ef1b78.png", "tileimageuri": "https://productimages.withfloats.com/tile/698af4fc8c165a34c7ef1b78.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-10T09:05:57.148Z", "updatedon": "2026-05-06T08:38:36.185Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rosuvastatin-ezetimibe-40-10-mg/2299", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REVOSTATIN EZ 40", "category": "CARDIOLOGYRANGE", "tags": [ "rosuvastatin ezetimibe 40 10 mg uses", "what is rosuvastatin ezetimibe 40/10 mg used for", "rosuvastatin ezetimibe combination benefits", "rosuvastatin ezetimibe tablets composition", "when to take rosuvastatin ezetimibe 40 10 mg", "rosuvastatin ezetimibe 40 10 mg side effects", "rosuvastatin ezetimibe interaction with food", "rosuvastatin ezetimibe 40 10 mg tablet price", "rosuvastatin ezetimibe 40 10 mg tablet cost", "rosuvastatin ezetimibe 40 10 mg manufacturer", "rosuvastatin ezetimibe 40/10 mg vs rosuvastatin 40 mg", "rosuvastatin ezetimibe 40 10 mg india", "rosuvastatin ezetimibe manufacturer india", "rosuvastatin ezetimibe 40 10 mg dosage for elderly", "rosuvastatin ezetimibe liver function monitoring", "rosuvastatin 40mg ezetimibe 10mg tab", "rosuvastatin ezetimibe", "rosuvastatin ezetimibe 40/10", "rosuvastatin ezetimibe side effects", "rosuvastatin ezetimibe tablet uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696f2a8662728a2493fefee6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rabeprazole Sodium and Cinitapride Capsules", "description": "Rabeprazole Sodium and Cinitapride Capsules (RABISTRUM CT): Complete Product Overview\n\nDigestive disorders such as acidity, gastroesophageal reflux disease (GERD), and functional dyspepsia have become increasingly common due to changing lifestyles, stress, irregular eating habits, and dietary choices. These conditions not only cause discomfort but can significantly affect daily life, sleep quality, and overall well-being. Rabeprazole Sodium and Cinitapride Capsules, marketed under the brand name RABISTRUM CT, offer an advanced and effective solution for managing acid-related and motility-related gastrointestinal disorders.\n\nRABISTRUM CT combines two proven medicines that work together to reduce stomach acid production and improve digestive movement, providing faster and longer-lasting relief from symptoms such as heartburn, bloating, nausea, and indigestion.\n\nWhat is RABISTRUM CT?\n\nRABISTRUM CT is a fixed-dose combination of:\n\nRabeprazole Sodium – a proton pump inhibitor (PPI)\n\nCinitapride – a prokinetic agent\n\nThis dual-action formulation is designed to address both the excess acid production and delayed gastric emptying that commonly occur in acid-peptic disorders. By targeting the root causes of digestive discomfort, RABISTRUM CT provides comprehensive relief and promotes better digestive health.\n\nUses of Rabeprazole Sodium and Cinitapride Capsules\n\nRABISTRUM CT is commonly prescribed for the treatment of:\n\nGastroesophageal reflux disease (GERD)\n\nAcid reflux and heartburn\n\nFunctional dyspepsia\n\nChronic gastritis\n\nPeptic ulcer disease\n\nBloating and post-meal fullness\n\nNausea and vomiting related to gastric motility issues\n\nThis combination is particularly beneficial for patients who experience persistent symptoms despite using acid-suppressing therapy alone.\n\nHow RABISTRUM CT Works\n\nRABISTRUM CT works through a dual-mechanism approach that provides effective and balanced digestive relief.\n\nRole of Rabeprazole Sodium\n\nRabeprazole Sodium belongs to the proton pump inhibitor class and works by:\n\nBlocking the final step of acid production in the stomach\n\nReducing excess gastric acid secretion\n\nAllowing healing of inflamed or damaged stomach and esophageal lining\n\nThis helps relieve symptoms such as burning sensation, acid regurgitation, and stomach pain.\n\nRole of Cinitapride\n\nCinitapride is a gastroprokinetic agent that works by:\n\nEnhancing stomach and intestinal motility\n\nImproving gastric emptying\n\nReducing bloating, nausea, and fullness\n\nStrengthening lower esophageal sphincter tone to prevent reflux\n\nTogether, these actions make RABISTRUM CT more effective than single-drug therapy in many digestive conditions.\n\nKey Benefits of RABISTRUM CT\n\nRABISTRUM CT offers several advantages for patients suffering from acid-related and motility disorders:\n\n1. Comprehensive Digestive Relief\n\nBy reducing acid production and improving gut movement, it treats the root cause of symptoms rather than providing temporary relief.\n\n2. Effective Management of GERD\n\nRABISTRUM CT helps control acid reflux, preventing heartburn and acid regurgitation, especially during nighttime.\n\n3. Reduces Bloating and Fullness\n\nCinitapride improves gastric emptying, making patients feel lighter and more comfortable after meals.\n\n4. Faster Symptom Improvement\n\nThe combined action leads to quicker relief compared to monotherapy.\n\n5. Improves Quality of Life\n\nRelief from chronic digestive discomfort helps improve appetite, sleep, and daily functioning.\n\nDosage and Administration\n\nThe dosage of RABISTRUM CT should be determined by a healthcare professional based on the patient’s condition and response to treatment. Generally:\n\nThe capsule is taken once daily, preferably before meals\n\nIt should be swallowed whole with water\n\nDo not crush or chew the capsule\n\nFor best results, patients should follow dietary advice, avoid trigger foods, and maintain regular meal timings.\n\nPossible Side Effects of RABISTRUM CT\n\nLike all medicines, Rabeprazole Sodium and Cinitapride Capsules may cause side effects in some individuals.\n\nCommon Side Effects\n\nHeadache\n\nDiarrhea\n\nNausea\n\nAbdominal discomfort\n\nDry mouth\n\nDizziness\n\nThese side effects are usually mild and tend to resolve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nPersistent diarrhea\n\nAllergic reactions such as rash or itching\n\nIrregular heartbeat (rare)\n\nLong-term use may affect vitamin B12 absorption\n\nPatients should consult a doctor if side effects persist or worsen.\n\nPrecautions and Warnings\n\nRABISTRUM CT should be used under medical supervision\n\nPatients with liver disease should inform their doctor before use\n\nLong-term use should be monitored to avoid nutritional deficiencies\n\nPregnant and breastfeeding women should consult a healthcare provider\n\nAvoid alcohol as it may worsen stomach irritation\n\nWho Should Use RABISTRUM CT?\n\nRABISTRUM CT is suitable for:\n\nAdults with GERD or chronic acidity\n\nPatients with functional dyspepsia and bloating\n\nIndividuals experiencing delayed gastric emptying\n\nPatients who do not respond adequately to PPIs alone\n\nIt is not recommended for children unless prescribed by a doctor.\n\nLifestyle Tips to Support Treatment\n\nTo enhance the effectiveness of RABISTRUM CT:\n\nEat smaller, frequent meals\n\nAvoid spicy, fatty, and acidic foods\n\nDo not lie down immediately after eating\n\nReduce stress through relaxation techniques\n\nMaintain a healthy weight\n\nConclusion\n\nRabeprazole Sodium and Cinitapride Capsules (RABISTRUM CT) provide a powerful and well-balanced solution for managing acid-related and digestive motility disorders. By combining acid suppression with improved gastric movement, RABISTRUM CT offers faster relief, longer-lasting results, and improved quality of life for patients struggling with chronic digestive discomfort.\n\nWhen used as prescribed and supported by healthy lifestyle choices, RABISTRUM CT becomes a reliable and effective option for comprehensive gastrointestinal care.", "price": 185.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2281, "imageuri": "https://productimages.withfloats.com/actual/696f2a88356da1ccb9841c5b.png", "tileimageuri": "https://productimages.withfloats.com/tile/696f2a88356da1ccb9841c5b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-20T07:11:02.268Z", "updatedon": "2026-03-12T11:25:45.263Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rabeprazole-sodium-and-cinitapride-capsules/2281", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RABISTRUM CT", "category": "GASTROLOGYRANGE", "tags": [ "rabeprazole sodium and cinitapride capsules uses", "rabeprazole cinitapride capsule combination", "rabeprazole sodium cinitapride capsules price", "rabeprazole and cinitapride capsules dosage", "rabeprazole cinitapride capsules for acidity", "rabeprazole sodium cinitapride capsules benefits", "best rabeprazole sodium and cinitapride capsules in India", "rabeprazole cinitapride capsules for acid reflux", "rabeprazole sodium and cinitapride capsules for GERD", "rabeprazole cinitapride capsules for indigestion", "rabeprazole sodium and cinitapride capsules side effects", "rabeprazole cinitapride capsules for gas and bloating", "rabeprazole sodium cinitapride capsules for gastritis", "rabeprazole cinitapride capsules for delayed gastric emptying", "rabeprazole sodium and cinitapride capsules for heartburn", "rabeprazole cinitapride capsules for functional dyspepsia", "rabeprazole sodium and cinitapride capsules manufacturer India", "rabeprazole cinitapride capsules pharma company", "rabeprazole sodium and cinitapride capsules wholesale supplier", "rabeprazole cinitapride capsules third party manufacturing", "when to take rabeprazole and cinitapride capsules", "rabeprazole sodium and cinitapride capsules before food", "rabeprazole cinitapride capsules how it works", "rabeprazole sodium cinitapride capsules daily use", "rabeprazole cinitapride capsules for stomach pain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin and Linagliptin Tablets", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 324.0, "discountamount": 97.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/69de144aff27708f32d3a9ea.png", "tileimageuri": "https://productimages.withfloats.com/tile/69de144aff27708f32d3a9ea.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2026-05-23T07:06:09.535Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-and-linagliptin-tablets/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH LINA 25/5", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets", "help manage blood sugar levels", "2 diabetes mellitus", "Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2)", "fixed dose combination of empagliflozin and linagliptin tablets", "empagliflozin and linagliptin tablets uses", "empagliflozin and linagliptin tablets 25 mg", "empagliflozin 25 mg uses in hindi", "empagliflozin side effects", "fixed dose combination of empagliflozin and linagliptin tablets", "empagliflozin and linagliptin tablets uses", "empagliflozin and linagliptin uses in hindi", "empagliflozin and linagliptin uses", "fixed dose combination of empagliflozin and linagliptin tablets", "empagliflozin and linagliptin", "empagliflozin and linagliptin brands in india", "empagliflozin and linagliptin tablets uses", "empagliflozin and linagliptin brands", "empagliflozin and linagliptin tablet uses", "empagliflozin and linagliptin combination", "combination of empagliflozin and linagliptin", "empagliflozin and linagliptin tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }